TETRAPHASE PHARMACEUTICALS INC: accounts_payable
| Value | {"amount": 3599000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-03-31) |
| Status | current |
| Entity | TETRAPHASE PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/12edb65f-c463-4d7c-9168-ccefa4bebb7d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-18-010676 · Open the official SEC filing →Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001373707/accounts-payable/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/12edb65f-c463-4d7c-9168-ccefa4bebb7d
History
- no predecessors — first report